The Latest Breaking News from Pfizer

As Hong Kong’s outbreak became the deadliest in the world, among the aid Beijing sent to the financial hub were 1 million packets of honeysuckle, rhubarb root, sweet wormwood herb and other natural ingredients, all mixed according to principles of traditional Chinese medicine.

Right-wing anti-vax activist Dr. Sherri Tenpenny was ridiculed for her statements

When Covid-19 stalled the world's economic motor in early 2020, ICON CEO Steve Cutler and his team at the vaccine trials company revved up.

As governments prepare to live with COVID-19, some are questioning how much to rely on drugmakers to adapt vaccines to ward off future virus variants amid signs of tension between companies and regulators over the best approach, according to several sources familiar with the matter.

Pressure is increasing on the administration to go after drug patents.

The authorization for another booster arrives just as BA.2 becomes the dominant strain in the U.S.

Amid worst Covid-19 outbreak, city could turn pandemic into manageable endemic disease using self-isolation, self-testing and advanced drugs and vaccines

Many Americans can now get a second COVID-19 booster, but it’s hard to tell who really needs another shot right now and who could wait

BioNTech SE (NASDAQ:BNTX) reported Q4 FY21 revenues of €5.53 billion compared to €345.4 million a year ago, mainly due to high demand for the company's COVID-19 vaccine. BioNTech and its partner Pfizer Inc (NYSE:PFE) delivered approximately 2.6 billion doses of Comirnaty/BNT162b2 worldwide in 2021, including over 1 billion doses to low- and middle-income countries. As…